Authors:Ni Made Maharianingsih, I Ketut Sudirta, Ni Putu Aryati Suryaningsih Pages: 86 - 94 Abstract: The development of cases of COVID-19 (coronavirus disease 2019) in the province Bali to increase until it ranks 10 th in Indonesia. This study aims to determine the characteristics of patients and the description of drug use for COVID-19 patients at Karangasem Hospital Bali for the period April 2020-Aril 2021. This study used a descriptive observational method with a cross-sectional design through a retrospective data search. The research was carried out in May 2021, which was located at the RSUD Karangasem. The population of this study were all moderate to severe COVID-19 inpatients at RSUD Karangasem in the period April 2020 - April 2021. The number of respondents as a sample was 200 patients with purposive sampling technique. The data collected is in the form of secondary data, which comes from medical records of COVID-19 patients at Karangasem Hospital. The results of the study showed that the most COVID-19 patients in Karangasem RSUD were from adults as many as 109 people (54.5%). Clinical symptoms experienced by all patients were fever with body temperature 38°C for more than 3 days and headache (100%). Patients who had comorbid as many as 196 people (98%) with pneumonia being the highest comorbid as many as 102 people (51%). The length of hospitalization for patients is generally 0-7 days by 69% (138 people). The highest patient status experienced moderate degree of symptoms by 89% (178 people) and severe 11% (22 people). The most drugs given to patients was vitamin C intravenously by 71% (142 people), while antiviral drugs in the form of oseltamivir (tamiflu) became the least by 1% (2 people). The conclusion of the study is that the characteristics of moderate-to-severe COVID-19 patients are dominated by male adult patients, have comorbidities (98%), clinical symptoms experienced by all patients are fever for more than 3 days and headache, with hospitalization for more than 3 days. The type of drug that is most often used is for antipyretic analgesics is paracetamol, the type of antibiotic is azithromycin, the type of antiviral is favipiravir, the type of corticosteroid is dexamethasone. Keywords: COVID-19, treatment, characteristics PubDate: 2022-04-01 Issue No:Vol. 2, No. 2 (2022)
Authors:Nurchamidin Gobel Pages: 95 - 102 Abstract: Patients are one indicator of the quality of services we provide and patient satisfaction is a capital to get more patients and to get loyal patients (faithful). Loyal patients will reuse the same health services if they need it again. Even loyal patients will invite others to use the same health service facility. The purpose of this study is to describe the level of patient satisfaction. This type of research uses a descriptive method with concurrent data collection. The data collected is in the form of result data (observations and questionnaires). Concurrent data is primary data obtained during direct observation and questionnaires during the research. This research was conducted from the second week of December 2020 until the end of February 2021. The data obtained is based on the answers from respondents to the questionnaire that has been tested for validity and reliability and then distributed. Furthermore, processed and analyzed and seen the percentage level of patient satisfaction which is presented in tabular form. Based on the data obtained from the respondents' answers, it can be concluded that the description of the level of patient satisfaction in the pharmacy installation of ZUS Hospital North Gorontalo is in the good category, with an average percentage of 81%. The criterion aspect of the question that received the most positive response from the respondents was that the service procedures at IFRSUD ZUS Gorontalo Utara were fast and did not bother the patient' (94%) and on the aspect of the criteria the question is that whether the officers are fair in providing services' (63%). Things that need to be done to improve aspects of questions that are still in the sufficient category are by improving the pharmaceutical service process as a whole, conducting supervision and awareness for all parties. PubDate: 2022-04-09 Issue No:Vol. 2, No. 2 (2022)